BARBARO, MARIA RAFFAELLA
 Distribuzione geografica
Continente #
EU - Europa 2.655
NA - Nord America 2.574
AS - Asia 2.272
AF - Africa 256
SA - Sud America 163
OC - Oceania 15
Totale 7.935
Nazione #
US - Stati Uniti d'America 2.542
IT - Italia 1.317
SG - Singapore 790
CN - Cina 687
GB - Regno Unito 307
VN - Vietnam 239
DE - Germania 233
HK - Hong Kong 204
SE - Svezia 203
IN - India 133
BR - Brasile 118
RU - Federazione Russa 103
KR - Corea 99
NL - Olanda 97
FR - Francia 78
TG - Togo 74
IE - Irlanda 71
CI - Costa d'Avorio 70
FI - Finlandia 42
CH - Svizzera 38
ZA - Sudafrica 33
BE - Belgio 28
NG - Nigeria 26
JP - Giappone 25
CD - Congo 24
EE - Estonia 24
AT - Austria 23
SC - Seychelles 21
UA - Ucraina 21
AR - Argentina 20
ID - Indonesia 19
JO - Giordania 19
BG - Bulgaria 18
CA - Canada 17
ES - Italia 13
IR - Iran 13
EC - Ecuador 12
AU - Australia 11
BD - Bangladesh 8
MX - Messico 8
PL - Polonia 7
TR - Turchia 7
PT - Portogallo 6
AL - Albania 5
HR - Croazia 5
CO - Colombia 4
LT - Lituania 4
NZ - Nuova Zelanda 4
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KZ - Kazakistan 3
LV - Lettonia 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
YE - Yemen 3
AG - Antigua e Barbuda 2
DK - Danimarca 2
IQ - Iraq 2
KE - Kenya 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
PK - Pakistan 1
SM - San Marino 1
SR - Suriname 1
TJ - Tagikistan 1
Totale 7.935
Città #
Singapore 550
Ashburn 288
Bologna 263
Fairfield 249
Southend 241
Hefei 207
Hong Kong 198
Chandler 149
Santa Clara 136
Woodbridge 125
Milan 116
Seattle 111
Wilmington 109
Houston 108
Seoul 96
Cambridge 90
Rome 87
Beijing 85
Boardman 81
Lomé 74
Brescia 71
Abidjan 70
Princeton 70
Ann Arbor 69
Dublin 69
Ho Chi Minh City 56
Dong Ket 54
Florence 54
Frankfurt am Main 53
Hanoi 41
Los Angeles 39
Munich 35
Nanjing 34
New York 34
Padova 30
Naples 28
Dallas 27
Westminster 26
Berlin 24
Lubumbashi 23
Redondo Beach 23
Turin 23
Abeokuta 22
Bengaluru 22
Helsinki 22
Bern 21
San Diego 20
Amman 19
Tokyo 19
São Paulo 18
Brussels 16
Changsha 16
Nuremberg 16
Sofia 15
Parma 14
Pisa 14
Redmond 14
Buffalo 13
Jakarta 13
Lappeenranta 13
Vienna 13
Amsterdam 12
Beerse 12
Falls Church 12
Hyderabad 12
London 12
Saint Petersburg 12
Ardabil 10
Pomigliano d'Arco 10
Chicago 9
Denver 9
Jinan 9
Modena 9
Nanchang 9
Ravenna 9
Shanghai 9
Ascoli Piceno 8
Des Moines 8
Lausanne 8
Phoenix 8
Poplar 8
Pune 8
Anguillara Sabazia 7
Bari 7
Cesena 7
Dearborn 7
Guangzhou 7
Jiaxing 7
Johannesburg 7
Moscow 7
Orem 7
San Jose 7
Tongling 7
Verona 7
Wuhan 7
Catania 6
Chapel Hill 6
Civitanova Marche 6
Council Bluffs 6
Falkenstein 6
Totale 4.960
Nome #
Management of Irritable Bowel Syndrome With Diarrhea 265
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 265
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 246
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 245
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 239
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 231
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 205
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 198
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 191
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 183
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 179
null 179
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 174
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 174
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 169
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 169
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 168
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 164
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 159
Diagnostic challenges of symptomatic uncomplicated diverticular disease 159
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 157
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 155
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 152
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 148
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 144
Nerve fiber overgrowth in patients with symptomatic diverticular disease 140
Chronic constipation: from pathophysiology to management 137
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 137
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 136
Implications of SARS-CoV-2 infection for neurogastroenterology 135
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 133
Cytochromes b561: ascorbate-mediated trans-membrane electron transport 130
Post COVID-19 irritable bowel syndrome 125
Treatment of diverticular disease with aminosalicylates: The evidence 123
Pathophysiology and Clinical Management of Bile Acid Diarrhea 120
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 119
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 115
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort - Results of an International Multicenter Randomized Controlled Trial 115
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons 114
Recent advances in understanding non-celiac gluten sensitivity 114
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis 112
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (Front. Nutr., (2021), 8, (718356), 10.3389/fnut.2021.718356) 109
Microbiota modulation in disorders of gut-brain interaction 106
The role of microbiota and its modulation in colonic diverticular disease 106
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients. 105
null 101
Pre- and probiotic overview 97
Gut microbiota signatures and modulation in irritable bowel syndrome 96
The Role of Microbiota in Upper Gastrointestinal Cancers 95
AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea 90
null 81
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 75
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms 75
Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry 74
Role of inflammation in pediatric irritable bowel syndrome 73
Letter: Post-COVID-19 disorders of gut–brain interaction (DGBI)—just post-infectious or a multifaceted entity? Authors' reply 57
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome—Authors' reply 46
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 3
Totale 8.112
Categoria #
all - tutte 23.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 15 18 46 54 64 35 114
2021/2022882 70 44 17 36 75 47 44 44 53 24 325 103
2022/20231.053 79 216 75 83 79 84 34 91 157 24 67 64
2023/2024594 21 60 40 57 70 69 23 30 30 86 64 44
2024/20252.109 116 266 190 203 275 104 148 127 75 140 158 307
2025/20261.918 310 381 332 338 361 196 0 0 0 0 0 0
Totale 8.112